Cancer Cell Biology

You have full text access to this OnlineOpen article

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells

  1. Maylis Dagouassat1,
  2. Nadine Suffee1,
  3. Hanna Hlawaty1,
  4. Oualid Haddad1,
  5. Faten Charni1,
  6. Christelle Laguillier2,
  7. Roger Vassy3,
  8. Loïc Martin4,
  9. Pierre-Olivier Schischmanoff5,
  10. Liliane Gattegno1,6,
  11. Olivier Oudar1,
  12. Angela Sutton1,6,†,
  13. Nathalie Charnaux1,6,†,‡,*

Article first published online: 29 JUL 2009

DOI: 10.1002/ijc.24800

Issue

International Journal of Cancer

International Journal of Cancer

Volume 126, Issue 5, pages 1095–1108, 1 March 2010

Additional Information

How to Cite

Dagouassat, M., Suffee, N., Hlawaty, H., Haddad, O., Charni, F., Laguillier, C., Vassy, R., Martin, L., Schischmanoff, P.-O., Gattegno, L., Oudar, O., Sutton, A. and Charnaux, N. (2010), Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int. J. Cancer, 126: 1095–1108. doi: 10.1002/ijc.24800

Author Information

  1. 1

    INSERM U698, Bioingénierie cardiovasculaire, Université Paris 13, Bobigny, France

  2. 2

    Laboratoire de Biochimie, Hôpital Charles Foix APHP, Ivry-sur-Seine, France

  3. 3

    CNRS UMR 7033, Université Paris 13, Bobigny, France

  4. 4

    CEA Saclay, Gif-sur-Yvette, France

  5. 5

    Laboratoire de Biochimie, Hôpital Avicenne AP-HP, Bobigny, France

  6. 6

    Laboratoire de Biochimie, Hôpital Jean Verdier AP-HP, Bondy, France

  1. †

    The last two authors contributed equally to the work.

  2. ‡

    Fax: 33-1-48-02-65-03

*INSERM U698 Bioingénierie cardiovasculaire, UFR SMBH, Université Paris 13; 74, rue Marcel Cachin, F-93017, Bobigny, France

Publication History

  1. Issue published online: 27 DEC 2009
  2. Article first published online: 29 JUL 2009
  3. Accepted manuscript online: 29 JUL 2009 12:00AM EST
  4. Manuscript Accepted: 23 JUL 2009
  5. Manuscript Received: 12 JAN 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (777K)

References

  • 1
    Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J 2008; 411: 1–18.
  • 2
    Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655–69.
  • 3
    Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125–72.
  • 4
    Reeves HL, Friedman SL. Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci 2002; 7: d808–26.
  • 5
    Desmoulière A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004; 48: 509–17.
  • 6
    De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429–47.
  • 7
    Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 2005; 65: 4728–38.
  • 8
    Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247–50.
  • 9
    Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci 2002; 7: d1899–914.
  • 10
    Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2: 108–15.
  • 11
    Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res 2007; 5: 21–33.
  • 12
    Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, et al. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Mol Cancer Ther 2007; 6: 2948–58.
  • 13
    Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–6.
  • 14
    Maher JJ, Lozier JS, Scott MK. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. JPhysiol 1998; 275: 847–53.
  • 15
    Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999; 29: 140–8.
  • 16
    Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol 2003; 285: G949–58.
  • 17
    Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217–42.
  • 18
    Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415–25.
  • 19
    Lau EK, Paavola CD, Johnson Z, Gaudry JP, Geretti JP, Borlat F, Kungl AJ, Proudfoot AE, Handel TM. Identification of the glycosaminoglycans binding site of the CC chemokine. MCP-1. J Biol Chem 2004; 279: 22294–305.
  • 20
    Faouzi S, Le Bail B, Neaud V, Boussarie L, Saric J, Bioulac-Sage P, Balabaud C, Rosenbaum J. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 1999; 30: 275–84.
  • 21
    Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, Nagamori S, Takeuchi K, Abe K, Kyogoku M. Establishment of a new human cell line. LI90, exhibiting characteristics of hepatic. Ito (fat-storing) cells. Lab Invest 1995; 72: 731–9.
  • 22
    Ueki N, Ohkawa T, Yamamura H, Takahashi K, Tsutsui T, Kawai Y, Yokoyama Y, Amuro Y, Toshikazu H, Higashino K. Induction of calponin-h1 by transforming growth factor-β1 in cultured human Ito cells. LI90. Biochim Biophys Acta 1998; 1403: 28–36.
  • 23
    Ozaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002; 36: 169–78.
  • 24
    Cheng J, Imanishi H, Liu W, Iwasaki A, Ueki N, Nakamura H, Hada T. Inhibition of the expression of α-smooth muscle actin in human hepatic stellate cell line. LI90, by a selective cyclooxygenase 2 inhibitor. NS-398. Biochem Biophys Res Commun 2002; 297: 1128–34.
  • 25
    Iwamoto K, Kanno K, Hyogo H, Yamagishi S, Takeuchi M, Tazuma S, Chayama K. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol 2008; 43: 298–304.
  • 26
    Hozawa S, Nakamura T, Nakano M, Adachi M, Tanaka H, Takahashi Y, Tetsuya M, Miyata N, Soma H, Hibi T. Induction of matrix metalloproteinase-1 gene transcription by tumour necrosis factor alpha via the p50/p50 homodimer of nuclear factor-kappa B in activated human hepatic stellate cells. Liver Int 2008; 28: 1418–25.
  • 27
    Sugimoto R, Enjoji M, Nakamuta M, Ohta S, Kohjima M, Fukushima M, Kuniyoshi M, Arimura E, Morizono S, Kotoh K, Nawata H. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int 2005; 25: 420–8.
  • 28
    Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Yokoyama T, Takii Y, Mori T, Yatsuhashi H, Eguchi K, Ishibashi H. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci 2006; 78: 2510–5.
  • 29
    Kanno K, Tazuma S, Nishioka T, Hyogo H, Chayama K. Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression. Dig Dis Sci 2005; 50: 942–8.
  • 30
    Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251–62.
  • 31
    Wu X, Fan J, Wang X, Zhou J, Qiu S, Yu Y, Liu Y, Tang Z. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochem Biophys Res Commun 2007; 355: 866–71.
  • 32
    Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4: 359–65.
  • 33
    Higashi N, Kojima N, Miura M, Imai K, Sato M, Senoo H. Cell-cell junctions between mammalian (human and rat) hepatic stellate cells. Cell Tissue Res 2004; 317: 35–43.
  • 34
    Starzec A, Briane D, Kraemer M, Kouyoumdjian JC, Moretti JL, Beaupain R, Oudar O. Spatial organization of three-dimensional cocultures of adriamycin-sensitive and -resistant human breast cancer MCF-7 cells. Biol Cell 2003; 95: 257–64.
  • 35
    Thomas RJ, Bennett A, Thomson B, Shakesheff KM. Hepatic stellate cells on poly(DL-lactic acid) surfaces control the formation of 3D hepatocyte co-culture aggregates in vitro. Eur Cell Mater 2006; 11: 16–26.
  • 36
    Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J. Hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor. Hepatology 1997; 26: 1458–66.
  • 37
    Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC, Desmoulière A, Kisiel W, Rosenbaum J. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000; 275: 35565–9.
  • 38
    Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, Vizzutti F, Anania FA, Milani S, Rombouts K, Laffi G, Pinzani M, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005; 42: 1339–48.
  • 39
    Marra F, Delogu W, Petrai I, Pastacaldi S, Bonacchi A, Efsen E, Aleffi S, Bertolani C, Pinzani M, Gentilini P. Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2004; 287: G18–26.
  • 40
    Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol 1994; 55: 120–6.
  • 41
    Mühlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Schölmerich J, Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003; 125: 1085–93.
  • 42
    Hogaboam CM, Bone-Larson CL, Steinhauser ML, Matsukawa A, Gosling J, Boring L, Charo IF, Simpson KJ, Lukacs NW, Kunkel SL. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor-2. Am J Pathol 2000; 156: 1245–52.
  • 43
    Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer 2006; 118: 335–45.
  • 44
    Clement S, Juge-Aubry C, Sgroi A, Conzelmann S, Pazienza V, Pittet-Cuenod B, Meier CA, Negro F. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 2008; 48: 799–807.
  • 45
    Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004; 14: 149–54.
  • 46
    Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD, Zhang J. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 2007; 67: 3646–53.
  • 47
    Youngs SJ, Ali SA, Toub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71: 773–8.
  • 48
    Lebrecht A, Grimm C, Lantzsch T, Ludwig E, Hefler L, Ulbrich E, Koebl H. Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol 2004; 25: 14–7.
  • 49
    Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S, Reinthaller A, Kainz C. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 1999; 81: 855–9.
  • 50
    Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, Beaugrand M, Charnaux N. Chemokine system polymorphism, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World J Gastroenterol 2008; 14: 713–9.
  • 51
    Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, Trinchet JC, Beaugrand M, Gattegno L, Charnaux N. Lack of association of some chemokine system polymorphism with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 2007; 19: 425–31.
  • 52
    Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385–92.
  • 53
    Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996; 23: 1341–4.
  • 54
    Chu JH, Yu S, Hayward SW, Chan FL. Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Prostate 2009; 69: 428–2.
  • 55
    Lang SH, Stark M, Collins A, Paul AB, Stower MJ, Maitland NJ. Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ 2001; 12: 631–40.
  • 56
    Sodek KL, Rinquette MJ, Brown TJ. Compact spheroid formation by ovarian cancer cells is associated with contractile behaviour and an invasive phenotype. Int J Cancer 2009; 124: 2060–70.
  • 57
    Smith RE, Hogaboam CM, Strieter RM, Lukacs NW, Kunkel SL. Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion. J Leukoc Biol 1997; 62: 612–9.
  • 58
    Carr MW, Alon R, Springer TA. The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 1996; 4: 179–87.
  • 59
    Chakravarty L, Rogers L, Quach T, Breckenridge S, Kolattukudy PE. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J Biol Chem 1998; 273: 29641–7.
  • 60
    Douglas MS, Ali S, Rix DA, Zhang JG, Kirby JA. Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. Immunology 1997; 92: 512–8.
  • 61
    Proudfoot AE, Handel TM, Johnson Z, Lau EK, Liwang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 2003; 100: 1885–90.
View Full Article (HTML) Get PDF (777K)